pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4776-1 |
Genomic Coordinates | chr2: 212926257 - 212926336 |
Description | Homo sapiens miR-4776-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
pre-miRNA | hsa-mir-4776-2 |
Genomic Coordinates | chr2: 212926257 - 212926336 |
Description | Homo sapiens miR-4776-2 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4776-5p | |||||||||||||||||||||||||||
Sequence | 10| GUGGACCAGGAUGGCAAGGGCU |31 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FADS6 | ||||||||||||||||||||
Synonyms | FP18279 | ||||||||||||||||||||
Description | fatty acid desaturase 6 | ||||||||||||||||||||
Transcript | NM_178128 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FADS6 | |||||||||||||||||||||
3'UTR of FADS6 (miRNA target sites are highlighted) |
>FADS6|NM_178128|3'UTR 1 TGAGGCCGGGCCGGTGCAGCCACCCTGCCCCTCCCTGGCCTGGCCCTGGCCCTCCTGCTGCTGCTGGTCCAGGGGGTGTG 81 GCTCAGTGGCTGGTGGTGGACCTGGAGAGTGGAGGCACCGGCCAGGCAGGGGGGCAGGGGAGCTCAGGCCTGGGGTCTGG 161 GGGCCACCTGCCTTGCGTGCTTTTCTGGGTTTTGAGGGGTGTCTGGGTGAAGCGGTAATGGTGGCTGTGCATTCTGGTCA 241 GTCTGGACCTCAGCAACTTCATCTCAGGACTAAAGAGCTGGGTCCTTCCCCCTGCTCCATCTGAGCCTTGGTAGGGTTAA 321 AGGGAGGTGACAGGGTGAAGAGGGATCCTGTGCAGGGGCCACCTGGGAGATAGCAGGGGGCACAGAGAGAACAGGGTCAG 401 CTCCCTCGGCTGGGACCTCCCTGGCATTGGGAGAGCCCCACACGGCCTTGGCTATTGCTTCCTTCAGGCTCTGCCCACCA 481 AGGTGCCCTCTCCCCGGGGACCTTAGGGTGAGCTTGCTTTTGGCAGGCCTTCCTCGATCCTCAGCCAAAGGAACCTGTGC 561 AAGACACTGGCTCAGCAGTTCCCCAGGCCACAGTATCAGCAAGATAAAAGTGAGTGTGTTTTGTCGGGAGGGAACTCCAG 641 GGGAAGTGAGGGGAGAAGGTTCCCCAGGGACAGAGTTAGGGAAAGAGTATAAATAGCCAGCCAGGGGCGGTGGCTCATGC 721 CTGTAATCCCAGCACTTTGGGAGGCCAAGGCGGGTGGATCGCGAGATCAGGAGCTCGAGACCACCCTGGCCAACATGGTG 801 AAACCCCGTCTCTACTAAAAATACAAAAAATTAGCTGGATGTGGTGGCATACACTTGTAGTCCCAGCTACTTGGCAGGCT 881 GAGGCAGAAGAATCACCTGAACCCGGGAGGTGGAGGTTGCAGTGAGCCAAGATTGCACCATTGCATTCCAGCCTGGGTGA 961 CAGAGCGAGACTCCATCTCAAAAAAATAAAAAAATAAAAAATAAGACTCCCGTTCAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_178128 | 3UTR | CCCUCCUGCUGCUGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000310226.6 | 3UTR | AGGGGGUGUGGCUCAGUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000310226.6 | 3UTR | AGGGGGUGUGGCUCAGUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
30 hsa-miR-4776-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT303862 | MAT2A | methionine adenosyltransferase 2A | 2 | 4 | ||||||||
MIRT445702 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | 2 | 4 | ||||||||
MIRT451664 | KRT8 | keratin 8 | 2 | 4 | ||||||||
MIRT456718 | TMEM239 | transmembrane protein 239 | 2 | 2 | ||||||||
MIRT462899 | ZNRF3 | zinc and ring finger 3 | 2 | 2 | ||||||||
MIRT469058 | RNF20 | ring finger protein 20 | 2 | 2 | ||||||||
MIRT476392 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 8 | ||||||||
MIRT477147 | FADS1 | fatty acid desaturase 1 | 2 | 8 | ||||||||
MIRT479187 | CLCN5 | chloride voltage-gated channel 5 | 2 | 6 | ||||||||
MIRT480935 | BBX | BBX, HMG-box containing | 2 | 8 | ||||||||
MIRT496801 | WNT2B | Wnt family member 2B | 2 | 2 | ||||||||
MIRT503537 | SNTN | sentan, cilia apical structure protein | 2 | 4 | ||||||||
MIRT507648 | CREBRF | CREB3 regulatory factor | 2 | 4 | ||||||||
MIRT507918 | C2orf72 | chromosome 2 open reading frame 72 | 2 | 4 | ||||||||
MIRT510817 | SBNO1 | strawberry notch homolog 1 | 2 | 4 | ||||||||
MIRT523221 | HIST1H3A | histone cluster 1 H3 family member a | 2 | 2 | ||||||||
MIRT529829 | ARGFX | arginine-fifty homeobox | 2 | 2 | ||||||||
MIRT532355 | SLC1A4 | solute carrier family 1 member 4 | 2 | 2 | ||||||||
MIRT532401 | RAB44 | RAB44, member RAS oncogene family | 2 | 2 | ||||||||
MIRT535409 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT566060 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT571239 | FADS6 | fatty acid desaturase 6 | 2 | 2 | ||||||||
MIRT611144 | TNRC6B | trinucleotide repeat containing 6B | 2 | 4 | ||||||||
MIRT621399 | PYCRL | pyrroline-5-carboxylate reductase 3 | 2 | 2 | ||||||||
MIRT647404 | SSTR3 | somatostatin receptor 3 | 2 | 2 | ||||||||
MIRT654033 | SAMD12 | sterile alpha motif domain containing 12 | 2 | 2 | ||||||||
MIRT659428 | COL1A1 | collagen type I alpha 1 chain | 2 | 2 | ||||||||
MIRT662068 | ZNF284 | zinc finger protein 284 | 2 | 2 | ||||||||
MIRT663830 | AGBL5 | ATP/GTP binding protein like 5 | 2 | 4 | ||||||||
MIRT699963 | RREB1 | ras responsive element binding protein 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|